Displaying 1 - 1 of 1
| Active Ingredient | EPLERENONE |
| Therapeutic Class | ALDOSTERONE RECEPTOR ANTAGONIST |
| Indications | Hypertension, Chronic heart failure (NYHA class II-IV) with reduced ejection fraction |
| Caution | Hyperkalemia, Hypercholesterolaemia, hypertriglyceridaemia |
| Dose Range | Hypertension: Initially 50mg daily increased to a maximum of 50mg twice a day. HF: Initially 25mg daily, increased in 25mg increments, if tolerated, to a maximum of 50mg daily in a 4 week period. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |